SGR Advises Given Imaging in Acquisition of Medtronic’s Bravo pH Monitoring Business
ATLANTA (December 18, 2008) — On December 8th, a group of Smith, Gambrell & Russell attorneys assisted client Given Imaging Ltd. in finalizing the acquisition of the Bravo(R) pH monitoring business for the diagnosis of Gastroesophageal Reflux Disease (GERD) from Medtronic (NYSE: MDT) for $20 million. Jay Schwartz was lead counsel. Larry Colton, Bruce Crabtree, Eric Mandus, Jonathan Minnen, David Santi, Michelle Edwards, Jeff Bekiares, Emily Cacioppo, Julie Sebastian, and Chris Yarbrough were also part of the SGR team.
“We were delighted to be transaction counsel for one of Israel’s premier companies,” said Jonathan Minnen, relationship partner at SGR for Given Imaging, and chair of the Firm’s Israel Practice Group. “Given Imaging has made a tremendous contribution to healthcare through the development of capsule endoscopy, and the Bravo monitoring business will be a great addition to their product line.”